Entourage Health Announces Second Quarter 2022 Financial Results Call to be held on August 30, 2022
August 11, 2022 16:48 ET
|
Entourage Health Corp.
TORONTO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Irwin Naturals Cannabis Products to Be Available in Canada
August 04, 2022 08:22 ET
|
Irwin Naturals
LOS ANGELES, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), whose herbal supplements are already available in in 100,000 stores...
Entourage Health Signs Exclusive Licensing Agreement with Irwin Naturals to Produce and Distribute its Cannabis Products in Canada
August 04, 2022 07:47 ET
|
Entourage Health Corp.
Irwin-branded cannabis products will be first available to Starseed Medicinal patients in Q4 2022 Strategic nutraceuticals partnership follows recent release of recommendations for easing access to...
Entourage Health Provides Update on Credit Facilities’ Maturity Dates and Amends Outstanding Unsecured Convertible Debentures
July 29, 2022 18:02 ET
|
Entourage Health Corp.
TORONTO, July 29, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage Health Announces Amendments to its Credit Facilities to Improve Debt Position and Support Strategic Long-Term Growth
July 04, 2022 08:00 ET
|
Entourage Health Corp.
TORONTO, July 04, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage Health Announces $8.9 Million Upsize to Credit Facility and Implementation of Proposed Amendments to 8.5% Unsecured Convertible Debentures
June 27, 2022 11:15 ET
|
Entourage Health Corp.
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage Health Extends its Senior Secured Credit Facility Maturity Date
June 01, 2022 08:03 ET
|
Entourage Health Corp.
TORONTO, June 01, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage Health Reports Record First Quarter 2022 Financial Results
May 30, 2022 18:35 ET
|
Entourage Health Corp.
Gross revenue* of $17.4 million, up 28% sequentially and 37% year over year Total revenue of $15.8 million in Q1, 2022 represents a 17% sequential increase over Q4 2021Gross Profit Before Fair Value...
Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures
May 13, 2022 08:22 ET
|
Entourage Health Corp.
TORONTO, May 13, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health to Present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on May 11th
May 10, 2022 11:36 ET
|
Entourage Health Corp.
TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...